dalteparin has been researched along with Hemorrhagic Diathesis in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Recently, the use of safe-dose recombinant tissue-type plasminogen activator (rTPA) has been proposed for the treatment of moderate PE demonstrating to be safe and more effective than standard anticoagulation." | 2.50 | [Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature]. ( Cannone, M; La Torre, PP; Mele, A; Mele, M, 2014) |
| "Subjects with ESRD had an approximately 50% greater anticoagulant effect, determined by thrombin generation time prolongation, than controls at antifactor Xa activity concentrations of 0." | 1.32 | Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time. ( Brophy, DF; Carr, ME; Gehr, TW; Martin, EJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mele, M | 1 |
| Mele, A | 1 |
| La Torre, PP | 1 |
| Cannone, M | 1 |
| Brophy, DF | 1 |
| Martin, EJ | 1 |
| Gehr, TW | 1 |
| Carr, ME | 1 |
| Flordal, PA | 1 |
| Berggvist, D | 1 |
| Burmark, US | 1 |
| Ljungström, KG | 1 |
| Törngren, S | 1 |
1 review available for dalteparin and Hemorrhagic Diathesis
| Article | Year |
|---|---|
[Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature].
Topics: Aged, 80 and over; Anemia, Hypochromic; Anticoagulants; Bundle-Branch Block; Diabetes Complications; | 2014 |
1 trial available for dalteparin and Hemorrhagic Diathesis
| Article | Year |
|---|---|
Risk factors for major thromboembolism and bleeding tendency after elective general surgical operations. The Fragmin Multicentre Study Group.
Topics: Abdomen; Anticoagulants; Dalteparin; Elective Surgical Procedures; Hemorrhagic Disorders; Humans; Mu | 1996 |
1 other study available for dalteparin and Hemorrhagic Diathesis
| Article | Year |
|---|---|
Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time.
Topics: Adult; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Chronic Disease; Enoxaparin; Fact | 2004 |